News Sol-Gel Technologies Ltd. Börse Stuttgart

Equities

4SG

IL0011417206

Market Closed - Börse Stuttgart Other stock markets 09:36:50 2024-06-28 am EDT			5-day change	1st Jan Change
0.78 ^EUR	+11.43%		-5.45%	-27.78%

May. 28	Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	MT
May. 28	Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	May. 28	MT
Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024	May. 28	CI
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice	May. 28	AQ
HC Wainwright Adjusts Sol-Gel Technologies Price Target to $6 From $9, Maintains Buy Rating	May. 20	MT
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates	May. 20	AQ
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel	May. 16	AQ
Sol-Gel Technologies Ltd. and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize Twyneo® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel	May. 16	CI
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	Apr. 01	AQ
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	Mar. 13	AQ
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	Feb. 29	CI
Transcript : Sol-Gel Technologies Ltd. - Special Call	Dec. 06
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	Nov. 30	CI
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	Nov. 30	AQ
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	Nov. 28	AQ
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	Nov. 20	PU
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	Nov. 20	CI
HC Wainwright Cuts Sol-Gel Technologies' Price Target to $9 From $12, Keeps Buy Rating	Nov. 13	MT
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sol-Gel Technologies Ltd. Börse Stuttgart

Equities

4SG

IL0011417206

Summary

Filters